JPH06501013A - 蒸気形でのエフェドリンベースのデリバリー用のエフェドリンベース及びサリチル酸アルキル含有組成物 - Google Patents

蒸気形でのエフェドリンベースのデリバリー用のエフェドリンベース及びサリチル酸アルキル含有組成物

Info

Publication number
JPH06501013A
JPH06501013A JP3517007A JP51700791A JPH06501013A JP H06501013 A JPH06501013 A JP H06501013A JP 3517007 A JP3517007 A JP 3517007A JP 51700791 A JP51700791 A JP 51700791A JP H06501013 A JPH06501013 A JP H06501013A
Authority
JP
Japan
Prior art keywords
weight
salicylate
ephedrine
composition
mixtures
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3517007A
Other languages
English (en)
Japanese (ja)
Inventor
シン，ニッキシレシュ　ニハラ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of JPH06501013A publication Critical patent/JPH06501013A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
JP3517007A 1990-09-28 1991-09-26 蒸気形でのエフェドリンベースのデリバリー用のエフェドリンベース及びサリチル酸アルキル含有組成物 Pending JPH06501013A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/590,646 US5175152A (en) 1990-09-28 1990-09-28 Composition containing ephedrine base and alkyl salicylate for the delivery of ephedrine base in vapor form
US590,646 1990-09-28

Publications (1)

Publication Number Publication Date
JPH06501013A true JPH06501013A (ja) 1994-01-27

Family

ID=24363071

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3517007A Pending JPH06501013A (ja) 1990-09-28 1991-09-26 蒸気形でのエフェドリンベースのデリバリー用のエフェドリンベース及びサリチル酸アルキル含有組成物

Country Status (11)

Country Link
US (1) US5175152A (OSRAM)
JP (1) JPH06501013A (OSRAM)
CN (1) CN1060962A (OSRAM)
AU (1) AU8733991A (OSRAM)
IE (1) IE913405A1 (OSRAM)
MX (1) MX9101377A (OSRAM)
MY (1) MY108564A (OSRAM)
NZ (1) NZ239980A (OSRAM)
PT (1) PT99086A (OSRAM)
TW (1) TW215418B (OSRAM)
WO (1) WO1992005781A1 (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004115525A (ja) * 2002-09-27 2004-04-15 Alpharx Inc 抗炎症性化合物の局所搬送用搬送剤

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5853768A (en) * 1995-03-01 1998-12-29 Altadonna; James Topical preparation and method for pain relief
US5785988A (en) * 1996-05-10 1998-07-28 Fust; Charles A. Composition for freshening nostrils and sinus cavities
US6344210B2 (en) 1996-05-10 2002-02-05 Charles A. Fust Composition for freshening nostrils and sinus cavities
US5706800A (en) 1997-01-29 1998-01-13 Cronk; Peter J. Medicated nasal dilator
US6244265B1 (en) 1997-01-29 2001-06-12 Peter J. Cronk Adhesively applied external nasal strips and dilators containing medications and fragrances
US20060029653A1 (en) 1997-01-29 2006-02-09 Cronk Peter J Therapeutic delivery system
US6769428B2 (en) 1997-01-29 2004-08-03 Peter J. Cronk Adhesively applied external nasal strips and dilators containing medications and fragrances
US5948414A (en) * 1998-03-24 1999-09-07 Nouveau Technologies, Inc. Herbal based nasal spray
US7048953B2 (en) * 2000-04-03 2006-05-23 Inhalation, Inc. Methods and apparatus to prevent, treat and cure infections of the human respiratory system by pathogens causing severe acute respiratory syndrome (SARS)
US7150888B1 (en) 2000-04-03 2006-12-19 Inhalation, Inc. Methods and apparatus to prevent colds, influenzaes, tuberculosis and opportunistic infections of the human respiratory system
US6776778B2 (en) * 2000-12-18 2004-08-17 Allen L. Prince Nasal douche
WO2002094216A2 (en) * 2001-05-24 2002-11-28 Alexza Molecular Delivery Corporation Delivery of stimulants through an inhalation route
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
US7585493B2 (en) 2001-05-24 2009-09-08 Alexza Pharmaceuticals, Inc. Thin-film drug delivery article and method of use
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
EP1392262A1 (en) 2001-05-24 2004-03-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
CA2483917C (en) 2002-05-02 2013-07-30 President And Fellows Of Harvard College Formulations limiting spread of pulmonary infections
US20050220720A1 (en) * 2002-05-02 2005-10-06 David Edwards Formulations limiting spread of pulmonary infections
EP1625335A2 (en) 2003-05-21 2006-02-15 Alexza Pharmaceuticals, Inc. Optically ignited or electrically ignited self-contained heating unit and drug-supply unit employing same
US20050207983A1 (en) 2004-03-05 2005-09-22 Pulmatrix, Inc. Formulations decreasing particle exhalation
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
US20060019987A1 (en) * 2004-07-23 2006-01-26 Fust Charles A Methods and compositions for inhibiting, destroying, and/or inactivating viruses
EP1781360A1 (en) 2004-08-12 2007-05-09 Alexza Pharmaceuticals, Inc. Aerosol drug delivery device incorporating percussively activated heat packages
AU2006247077A1 (en) * 2005-05-18 2006-11-23 Pulmatrix Inc. Formulations for alteration of biophysical properties of mucosal lining
JP2010502310A (ja) 2006-08-30 2010-01-28 ディヴィッド・ウィリアム・スミス 押出成形された材料に単軸又は多軸方向の剛性を付与する方法及び同方法により得られる製品
US20080216828A1 (en) 2007-03-09 2008-09-11 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
WO2009047779A2 (en) * 2007-06-20 2009-04-16 Nikki Nikhilesh Singh Composition containing fentanyl base aromatic oils and alkyl salicylate for the delivery of fentanyl base in vapour form
JP5877201B2 (ja) 2010-08-30 2016-03-02 パルマトリックス，インコーポレイテッド 肺疾患を治療するための乾燥粉末製剤および方法
US20130164338A1 (en) 2010-08-30 2013-06-27 Pulmatrix, Inc. Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder
US9642798B2 (en) 2010-09-29 2017-05-09 Pulmatrix, Inc. Monovalent metal cation dry powders for inhalation
ES2710537T3 (es) 2010-09-29 2019-04-25 Pulmatrix Operating Co Inc Polvos secos catiónicos
HK1204989A1 (en) 2012-02-29 2015-12-11 Pulmatrix Operating Company, Inc. Inhalable dry powders
KR20150135328A (ko) 2013-04-01 2015-12-02 풀매트릭스 인코퍼레이티드 티오트로피움 건조 분말
WO2019152873A1 (en) 2018-02-02 2019-08-08 Alexza Pharmaceuticals, Inc. Electrical condensation aerosol device
CA3118158A1 (en) 2018-12-18 2020-06-25 The Procter & Gamble Company Personal care composition with increased vapor release

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2196322A (en) * 1937-12-04 1940-04-09 Squibb & Sons Inc Pharmaceutical
US2785103A (en) * 1953-12-31 1957-03-12 Abbott Lab L-desoxyephedrine inhalant preparation
BE555319A (OSRAM) * 1956-03-21 1900-01-01
US3236729A (en) * 1961-08-03 1966-02-22 Richardson Merrell Inc Control of nasal congestion
US3138526A (en) * 1962-11-06 1964-06-23 Hoffmann La Roche Compositions for treating bronchospastic disorders comprising theophylline, ephedrine, and 7-chloro-2-methylamino-5-phenyl-3h-1, 4-benzodiazepine-4-oxide
US3467754A (en) * 1966-08-10 1969-09-16 Mead Johnson & Co Bronchodilator expectorant elixir
US3639622A (en) * 1968-11-22 1972-02-01 Geigy Chem Corp Vasoconstricting and bronchodilating compositions and methods utilizing gallic acid and alkyl gallates
DD99927A1 (OSRAM) * 1972-10-23 1973-09-05
AU520987B2 (en) * 1978-05-08 1982-03-11 Victor Alexander Garten Anti-arthritic preparation
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
JPS5829706A (ja) * 1981-08-14 1983-02-22 Toko Yakuhin Kogyo Kk 消炎鎮痛外用剤
US4486436A (en) * 1982-07-22 1984-12-04 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4522826A (en) * 1984-02-08 1985-06-11 Richardson-Vicks Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
IT1199619B (it) * 1985-01-03 1988-12-30 Oece Ind Chimiche Spa Vernici additivate
FR2613225B2 (fr) * 1986-05-16 1989-10-27 Grenet Edouard Association d'huiles essentielles et de medicaments pour les voies respiratoires, et applications de cette association en tant qu'agent de protection des voies respiratoires, en presence de fumees et de gaz nocifs pour celles-ci, provenant notamment de la combustion d'hydrocarbures et du tabac

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004115525A (ja) * 2002-09-27 2004-04-15 Alpharx Inc 抗炎症性化合物の局所搬送用搬送剤

Also Published As

Publication number Publication date
TW215418B (OSRAM) 1993-11-01
IE913405A1 (en) 1992-04-08
AU8733991A (en) 1992-04-28
NZ239980A (en) 1996-10-28
PT99086A (pt) 1992-08-31
MY108564A (en) 1996-10-31
US5175152A (en) 1992-12-29
WO1992005781A1 (en) 1992-04-16
CN1060962A (zh) 1992-05-13
MX9101377A (es) 1992-05-04

Similar Documents

Publication Publication Date Title
JPH06501013A (ja) 蒸気形でのエフェドリンベースのデリバリー用のエフェドリンベース及びサリチル酸アルキル含有組成物
Morice et al. Effect of inhaled menthol on citric acid induced cough in normal subjects.
JP6941224B2 (ja) 疾患の処置のための鼻腔内エピネフリン製剤及び方法
KR100511730B1 (ko) 활성성분의 개선된 전달성을 갖는 조성물
MacLeod et al. Inhaled fentanyl aerosol in healthy volunteers: pharmacokinetics and pharmacodynamics
AU2002319422B2 (en) Aerosol formulations of delta8 tetrahydrocannabinol
US20100055048A1 (en) Acute treatment of headache with phenothiazine antipsychotics
US5496537A (en) Propofol hydrofluorocarbon propellant formulations
JP2006514633A (ja) 吸入によって送達される抗精神病薬を用いた頭痛の治療
WO2005020906A2 (en) Intranasal opioid compositions
AU2002319422A1 (en) Aerosol formulations of delta8 tetrahydrocannabinol
US20230137840A1 (en) Mint mask and methods of use thereof
UA119773C2 (uk) Комбінації тіотропію броміду, формотеролу і будесоніду для лікування хронічної обструктивної хвороби легень (хохл)
Pearman Cocaine: a review
US20060148837A1 (en) Compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction
CN102512676A (zh) 使用噻唑衍生物的方法
WO2009047779A2 (en) Composition containing fentanyl base aromatic oils and alkyl salicylate for the delivery of fentanyl base in vapour form
WO2008062453A2 (en) Composition containing nicotine base aromatic oils and alkyl salicylate for the delivery of nicotine base in vapour form
Chege et al. The relative bioavailability of salbutamol to the lung using urinary excretion following inhalation from a novel dry powder inhaler: the effect of inhalation rate and formulation
AU670794B2 (en) Use of cotinine to alleviate tobacco withdrawal syndrome
Bierman Adrenergic drugs
Bryson et al. Marijuana, nitrous oxide, and other inhaled drugs
CN119950500A (zh) 烟草减害和疼痛缓解产品及其方法
Wang-Fischer et al. Anesthesia of Laboratory Rats
Blake Principles of lung therapeutics